Chandra Has Khanduri

Title: Chandra Has Khanduri: Innovator in Pharmaceutical Patents

Introduction

Chandra Has Khanduri is a prominent inventor based in Gurgaon, India. He has made significant contributions to the field of pharmaceuticals, holding a total of 8 patents. His work primarily focuses on innovative formulations and processes that enhance the efficacy of treatments for various medical conditions.

Latest Patents

Among his latest patents, Khanduri has developed crystalline forms of ibrutinib. This invention relates to crystalline forms designated as Form S1, Form S2, Form S3, Form S4, and an amorphous form known as Form A1. These forms are crucial for the treatment of Bruton's tyrosine kinase (BTK) mediated diseases. Additionally, he has patented processes for the preparation of ertugliflozin co-crystals, specifically ertugliflozin-L-pyroglutamic acid (1:1) and ertugliflozin-L-proline (1:1) co-crystals. His work in this area is aimed at improving treatments for type 2 diabetes mellitus.

Career Highlights

Khanduri has worked with notable companies in the pharmaceutical industry, including Ranbaxy Laboratories, Inc. and Sun Pharmaceutical Industries Limited. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in drug formulations.

Collaborations

Throughout his career, Khanduri has collaborated with several professionals in the field. Some of his notable coworkers include Mukesh Kumar Madhra and Pankaj Kumar Singh. These collaborations have played a vital role in the development of his patented inventions.

Conclusion

Chandra Has Khanduri is a distinguished inventor whose work in pharmaceutical patents has made a significant impact on the industry. His innovative approaches to drug formulations continue to pave the way for advancements in medical treatments.